Background: Nasal continuous positive airway pressure (CPAP) is a well-established, widely used and effective treatment of obstructive sleep apnea syndrome (OSAS). Unfortunately, side effects are frequent during CPAP treatment. Objectives: Little is known about the effects of CPAP on infectious complications in patients with OSAS. Methods: We retrospectively analyzed the kinds and rate of infections of the upper airway in 246 consecutive patients (mean age, 59.7 years) with polysomnographically verified OSAS using CPAP with or without a heated humidifier and compared them with OSAS patients who received non-CPAP therapy. Results: Of the 246 patients, 40 received conservative therapy and 206 CPAP treatment, 36 of them with a heated humidifier. The mean follow-up period of the study group was 165.4 ± 92.1 weeks and did not differ between the three groups. Infectious diseases were frequent in all three groups, but patients using CPAP without humidifier suffered from upper airway infections significantly more frequently than controls (42.9 vs. 25%; p < 0.05), and more patients on CPAP therapy with humidifier than controls (22.2 vs. 2.5%; p < 0.01) reported an increased rate of upper airway infections since initiation of CPAP therapy or diagnosis of OSAS. Especially patients using a hot water bath humidifier who cleaned their devices inadequately had significantly more upper airway infections since diagnosis (57.1 vs. 20%; p < 0.05) or during the past 6 months (52.4 vs. 13.3%; p < 0.05) than patients who regularly cleaned CPAP machines, humidifiers and ventilatory circuits. Conclusions: Our results suggest that patients using CPAP therapy either with or without heated humidity seem to be at an increased risk of upper airway infections compared to conservatively treated patients.

Keywords:
Obstructive sleep apnea syndrome, Humidity, Continuous positive airway pressure
1.
Sullivan CE, Issa FG, Berthon-Jones M, Eves L: Reversal of obstructive sleep apnea by continuous positive airway pressure through the nares. Lancet 1981;i:862–865.
2.
Jenkinson C, Davies RJO, Mullins R, Stradling JR: Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomized prospective parallel trial. Lancet 1999;353:2100–2105.
3.
Krieger J, Grucker D, Sforza E, Chambron J, Kurtz D: Left ventricular ejection fraction in obstructive sleep apnea. Effects of long-term treatment with nasal continuous positive airway pressure. Chest 1991;100:917–921.
4.
Laks L: Pulmonary arterial pressure in sleep apnea. Sleep 1993;16:S41-S43.
5.
Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD: Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 1991;338:1480–1484.
6.
Nahmias J, Lao R, Karetzky M: Right ventricular dysfunction in obstructive sleep apnoea: Reversal with nasal continuous positive airway pressure. Eur Respir J 1996;9:945–951.
7.
Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, Wichert PV: Blood pressure and sleep apnea: Results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991;79:84–92.
8.
Suzuki M, Otsuka K, Guilleminault C: Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993;16:545–549.
9.
Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P: Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Chest 1995;107:375–381.
10.
Sanders MH, Gruendl CA, Rogers RM: Patient compliance with nasal CPAP therapy for sleep apnea. Chest 1986;90:330–333.
11.
Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ: Self-reported use of CPAP and benefits of CPAP therapy. Chest 1996;109:1470–1476.
12.
Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C: Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998;157:858–865.
13.
Massie CA, Hart RW, Peralez K, Richards GN: Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116:403–408.
14.
Boots RJ, Howe S, George N, Harris FM, Faoagali J: Clinical utility of hygroscopic heat and moisture exchangers in intensive care patients. Crit Care Med 1997;25:1707–1712.
15.
Bonten MJM, Bergmans DCJJ, Ambergen AW, de Leeuw PW, van der Geest S, Stobberingh EE, Gaillard CA: Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996;154:1339–1346.
16.
American Thoracic Society – Medical Section of the American Lung Association: Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989;139:559–568.
17.
American Academy of Sleep Medicine Task Force: Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–689.
18.
Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, Government Printing Office, 1968 (NIH publication No 204).
19.
Strohl KP, Arnold JL, Decker MJ, Hoekje PL, McFadden ER: Nasal flow-resistive responses to challenge with cold dry air. J Appl Physiol 1992;72:1243–1246.
20.
Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM: Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985;76:1375–1381.
21.
Simmons G, Wong E: Guideline for prevention of nosocomial pneumonia. Am J Infect Control 1983;11:230–244.
22.
ATS Consensus Statement: Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy and preventive strategies. Am J Respir Crit Care Med 1995;153:1711–1725.
23.
Craven DE, Steger KA, Barat LM, Duncan RA: Nosocomial pneumonia: Epidemiology and infection control. Intensive Care Med 1992;18(suppl 1):S3–9.
24.
Rauscher H, Formanek D, Popp W, Zwick H: Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993;103:1675–1680.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.